Pharma Journalist - Page 2 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AbbVie to Invest $1.4 Billion in North Carolina Campus

BioAegis and Prenosis Partner to Advance Precision ARDS Therapy

FDA Approves Merck’s New Two-Drug HIV Treatment Option

FDA Expands Tzield Use to Younger Children with Type 1 Diabetes

Boehringer Expands AI Footprint With London Innovation Hub

FDA Priority Review for PADCEV Combo in Bladder Cancer

Biocon Wins Canada Approval for Two Denosumab Biosimilars

Biogen Secures Global Rights to Felzartamab in China Deal

Lilly to Acquire Kelonia in $7 Billion Gene Therapy Deal

UCB to Acquire Neurona to Boost Epilepsy Pipeline